SCHEMBL6710260

SCHEMBL6710260

Cn1c(C(=O)Nc2ccc(Br)cc2-c2noc(=O)[nH]2)cc2c(Br)cc(Br)c(N)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.38
RXFP1 Q9HBX9 3/20 0.33
HIF1A Q16665 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HPGD P15428 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
KMT2A Q03164 4/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 3/20 0.32
LMNA P02545 3/20 0.32
TP53 P04637 1/20 0.32
HDAC1 Q13547 1/20 0.31
KDM4E B2RXH2 1/20 0.31
F11 P03951 1/20 0.31
GPR35 Q9HC97 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709886 0.91 GRIK1 (0.42) GRIK1RXFP1MAPTTP53F11
SCHEMBL6708833 0.90 GRIK1 (0.38) GRIK1RXFP1HIF1ANPSR1HPGD
SCHEMBL6708764 0.89 GRIK1 (0.32) GRIK1F11GPR35
SCHEMBL6708719 0.88 GRIK1 (0.38) GRIK1RXFP1HIF1ANPSR1HPGD
SCHEMBL6711947 0.82 GRIK1 (0.35) GRIK1RXFP1HIF1ANPSR1SMN1; SMN2
SCHEMBL6711606 0.82 GRIK1 (0.42) GRIK1RXFP1HIF1ANPSR1HPGD
SCHEMBL6710370 0.82 HIF1A (0.38) RXFP1HIF1ANPSR1HPGDSMN1; SMN2
SCHEMBL6707810 0.81 GRIK1 (0.42) GRIK1RXFP1MAPTTP53HDAC1
SCHEMBL6710409 0.81 GRIK1 (0.36) GRIK1RXFP1HIF1ANPSR1SMN1; SMN2
SCHEMBL6710225 0.80 GRIK1 (0.42) GRIK1RXFP1HIF1ANPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885RXFP1 3836/4885HIF1A 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.